British Prime Minister Boris Johnson described today as “safe” and “extremely effective” AstraZeneca vaccine/ Oxford against Covid-19, after its use was suspended by countries concerned about possible serious side effects.
“This vaccine is safe and works extremely well,” he told The Times, as reported by AMPE, while emphasizing that it is also “Relatively easy to distribute” and how “Available at cost price”.
In the meantime, the France expressed the hope that European medical experts will clarify the issues related to the safety of the AstraZeneca vaccine the day after tomorrow, Thursday, as experts warn that the decision of large European countries to suspend its use poses a greater risk to public health.
In a coordinated move, the European Union’s largest members – Germany, France and Italy – on Monday suspended the use of the AstraZeneca vaccine pending the outcome of an investigation by the European Medicines Agency (EMA). ) in isolated cases of bleeding, clots and low platelet count.
Sweden and Latvia have today suspended the same vaccine.
The World Health Organization and the EMA have announced, as has AstraZeneca, that there is no proven relationship.
“The choice is political,” Nicolas Magrini, director general of the Italian pharmaceutical company, told la Repubblica newspaper, according to Reuters.
According to the same source, Magrini described the AstraZeneca vaccine as safe and said that the cost-benefit ratio was “widely positive”. There have been eight deaths and four cases of serious side effects following vaccinations in Italy, he added.
French Health Minister Olivier Veran also told reporters that the risk-benefit ratio for the vaccine remains positive.
“We are waiting until Thursday afternoon for some kind of verdict from the European scientific community that will allow us to repeat the vaccination campaign,” Veran said. The head of the French vaccination campaign, Alain Fisse, stated that he expects the suspension to be temporary.

Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.